1. Adoptive transfer of functional SARS‐COV‐2‐specific immunity from donor graft to hematopoietic stem cell transplant recipients. Issue 11 (2nd September 2022) Authors: La Rosa, Corinna; Chiuppesi, Flavia; Park, Yoonsuh; Gendzekhadze, Ketevan; Zhou, Qiao; Faircloth, Katelyn; Kaltcheva, Teodora; Johnson, Daisy; Ortega Francisco, Sandra; Amanam, Idoroenyi; Otoukesh, Salman; Pullarkat, Vinod A.; Nakamura, Ryotaro; Diamond, Don J.; Forman, Stephen J.; Al Malki, Monz... Journal: American journal of hematology Issue: Volume 97:Issue 11(2022) Page Start: E404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma. (April 2019) Authors: Gupta, Rohan; Amanam, Idoroenyi; Rahmanuddin, Syed; Mambetsariev, Isa; Wang, Yingyu; Huang, Charity; Reckamp, Karen; Vora, Lalit; Salgia, Ravi Journal: American journal of clinical oncology Issue: Volume 42:Number 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Applications for Oncologic Drugs: A Descriptive Analysis of the Oncologic Drugs Advisory Committee Reviews. (5th March 2014) Authors: Chan, John K.; Kiet, Tuyen K.; Monk, Bradley J.; Young‐Lin, Nichole; Blansit, Kevin; Kapp, Daniel S.; Amanam, Idoroenyi Journal: Oncologist Issue: Volume 19:Number 3(2014) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Applications for Oncologic Drugs: A Descriptive Analysis of the Oncologic Drugs Advisory Committee Reviews. (5th March 2014) Authors: Chan, John K.; Kiet, Tuyen K.; Monk, Bradley J.; Young-Lin, Nichole; Blansit, Kevin; Kapp, Daniel S.; Amanam, Idoroenyi Journal: Oncologist Issue: Volume 19:Number 3(2014) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML). Issue 13 (10th November 2022) Authors: Ball, Brian J.; Arslan, Shukaib; Koller, Paul; Ngo, Dat; Afkhami, Michelle; Salhotra, Amandeep; Al-Malki, Monzr; Aribi, Ahmed; Ali, Haris; Sandhu, Karamjeet; Otoukesh, Salman; Amanam, Idoroenyi; Pourhassan, Hoda; Artz, Andrew; Curtin, Peter; Stein, Anthony; Nakamura, Ryotaro; Marcucci, Guido; Smi... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 13(2022) Page Start: 3232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Current and future therapies for advanced pancreatic cancer. Issue 1 (7th June 2017) Authors: Gupta, Rohan; Amanam, Idoroenyi; Chung, Vincent Other Names: Melstrom Laleh G. guestEditor.; Singh Gagandeep guestEditor.; Fong Yuman guestEditor. Journal: Journal of surgical oncology Issue: Volume 116:Issue 1(2017) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immune thrombocytopenia after immune checkpoint inhibitor therapy. (13th March 2021) Authors: Amanam, Idoroenyi; Gupta, Rohan; Pullarkat, Vinod; Mei, Matthew Journal: British journal of haematology Issue: Volume 193:Number 3(2021) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Inotuzumab ozogamicin is deliverable in relapsed ALL patients with end-stage renal disease on hemodialysis. Issue 13 (10th November 2022) Authors: Amanam, Idoroenyi; Ngo, Dat; Pullarkat, Vinod; Aldoss, Ibrahim Journal: Leukemia & lymphoma Issue: Volume 63:Issue 13(2022) Page Start: 3268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Progressive Neurologic Changes in a Patient With Metastatic Non–Small-Cell Lung Cancer: Cancer Effects or a Secondary Diagnosis?. Issue 1 (9th January 2021) Authors: Amanam, Idoroenyi; Mambetsariev, Isa; Gupta, Rohan; Salgia, Ravi Journal: JCO oncology practice Issue: Volume 17:Issue 1(2021) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The brigatinib experience: a new generation of therapy for ALK-positive non-small-cell lung cancer. (16th February 2018) Authors: Amanam, Idoroenyi; Gupta, Rohan; Mambetsariev, Isa; Salgia, Ravi Journal: Future oncology Issue: Volume 14:Number 19(2018) Page Start: 1897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗